Stryker Hip Lawsuit News: Claims in New Jersey Stryker Hip Recall Litigation Surpass 1,200, Bernstein Liebhard LLP Reports

The Firm is representing numerous Stryker hip recall clients who have filed claims in New Jersey Superior Court.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
Free Case Review
This is not at all surprising. Our Firm is representing numerous Stryker hip recall clients who have claims pending in this proceeding, and we continue to receive inquiries from individuals who were allegedly harmed by Rejuvenate and ABG II hip stems.

New York, NY (PRWEB) May 16, 2014

Stryker hip lawsuits (http://www.strykerhiprecallclaims.com/) filed on behalf of individuals who were allegedly injured by Rejuvenate and ABG II Modular-Neck Hip Stems continue to mount in a multicounty litigation underway in New Jersey’s Bergen County Superior Court, Bernstein Liebhard LLP reports. According to an updated Case List issued by the Court on May 15, 2014, at least 1,203 Stryker hip recall claims are now pending in the proceeding. The number of filings has increased by 249 since the last update was issued in April, when 954 Stryker hip lawsuit filings were noted. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)

“This is not at all surprising. Our Firm is representing numerous Stryker hip recall clients who have claims pending in this proceeding, and we continue to receive inquiries from individuals who were allegedly harmed by Rejuvenate and ABG II hip stems,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who have suffered debilitating complications allegedly related to the Stryker hip recall for Rejuvenate and ABG II hip stems.

Stryker Hip Recall
Stryker Rejuvenate and ABG II hip stems were recalled in July 2012, after post-market surveillance data indicated the metal components were prone to fretting and corrosion at the modular neck junction. According to the Stryker hip recall notice, this occurrence may cause patients to experience pain, swelling and adverse local tissue reactions that result in failure of the device and the need for surgery to remove and replace the hip. All patients fitted with a Rejuvenate or ABG II hip stem have been urged by Stryker to seek medical screening, whether or not they are experiencing any symptoms.*

Since the recall was announced, court documents indicate that hundreds of Rejuvenate and ABG II patients have filed Stryker hip lawsuits seeking compensation for alleged complications. In addition to the claims pending in New Jersey, more than 800 complaints have been filed in a federal multidistrict litigation underway in U.S. District Court, District of Minnesota. All of the claims make similar allegations regarding painful and often permanent injuries suffered by Stryker hip recipients, including metallosis, tissue necrosis, osteolysis, and premature device failure. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, No. 244)

Alleged victims of Stryker hip recall complications may be entitled to compensation. To learn more about filing a Stryker hip lawsuit, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to arrange for a free, no-obligation case review.

*literature.ortho.stryker.com/files/REJUV_COM_23.pdf

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.strykerhiprecallclaims.com/
https://plus.google.com/115936073311125306742?rel=author